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VASCULAR PROSTHESIS 
This application is the Us. national phase under 35 U.S.C. 
371 of International Application No. PCT/IT2006/000527, 
?led 11 Jul. 2006, which designated the U.S., the entire con 
tents of which is hereby incorporated by reference. 
The present invention refers to a vascular endoprosthesis, 
apt to exclude an aneurysmal portion of the aorta, and in 
particular of the aortic arch or the thoraco-abdominal aorta. 
As is well-known, the aorta is the most important artery 
supplying blood to the organism. It originates from the heart 
as ascending aorta and continues at the thoracic level as aortic 
arch and descending aorta, subsequently extending into the 
abdomen where it divides, at the level of the bifurcation, into 
two iliac arteries. Among the arteries originating from the 
aorta, some are of fundamental importance: the right common 
carotid artery, the left common carotid artery and the left 
subclavian artery, all of which initiate from the aortic arch and 
supply blood to the cerebral region and to the upper limbs; the 
intercostal arteries, originating from the descending thoracic 
aorta to supply the spinal cord; and lastly, the visceral arteries, 
extending from the upper abdominal section to supply all the 
abdominal organs. 
The aorta has an average diameter of 2 cm. and its wall is 
made of elastic ?bres (primarily in the thoracic section) and 
muscular ?bres (primarily in the abdominal section). Aneu 
rysms, that is dilations of the aorta, are among the most severe 
pathologies affecting the aorta, in particular the thoracic and 
thoraco-abdominal portion. 
Conventional surgery for treatment of the aneurysmal 
aorta-thoracic and/or thoraco-abdominal4calls for a resec 
tion of the aorta portion involved and its replacement with a 
prosthesis that is anastomosed between the two vascular 
stumps resulting from the resection. Generally, during this 
procedure the patient is subjected to hypothermic extracor 
poreal circulation. 
Despite the remarkable advances made in conventional 
surgery over the past few years in treating aneurysms of the 
aortic arch and the thoraco-abdominal aorta, major problems 
that decisively condition surgical results remain unresolved, 
as conventional surgery is still burdened by high mortality 
and morbidity, with a particularly high risk of paraplegia, 
cerebral ischemia, respiratory and/or renal insuf?ciency, etc. 
The major problems conditioning surgical results ensue from 
the lengthy times required for the “aortic cross-clamping” to 
suture the prosthesis in situ, and from the use of extracorpo 
real circulation systems, the latter intended to protect such 
particularly sensitive organs as the central nervous system, 
the cardiovascular system, renal function, etc. 
The advent of endovascular surgery in the surgical pan 
orama of the last decade has certainly modi?ed and improved 
surgical results for treatment of the aneurysmal pathology, 
especially of the descending thoracic aorta, signi?cantly 
decreasing the incidence of such serious complications as 
paraplegia. The endovascular approach requires no resection 
of the aortic portion involved by the aneurysm, but simply the 
insertion of an endoprosthesis that reproduces the correct 
vascular diameter, thereby excluding the aneurysm and re 
establishing a correct blood ?ow. Said signi?cant improve 
ment is certainly attributable to the elimination of aortic 
cross-clamping, the need for extracorporeal circulation and of 
other organ protection systems requiring lengthy and exten 
sive use of anesthesia. 
Regrettably, endovascular surgery, certainly valid for the 
descending thoracic aorta, has found no effective application 
for the aortic arch and for the thoraco-abdominal aorta, where 












exclusively to a “hybrid” treatment combining a conventional 
surgical approach and an endovascular approach. 
Thus the technical problem presented and solved by the 
present invention is to provide a vascular prosthesis capable 
of overcoming the drawbacks mentioned hereto with refer 
ence to the known procedure. 
The problem is solved by a vascular endoprosthesis as per 
claim 1. 
Preferred features of the present invention are provided for 
in the dependent claims thereof. 
The present invention provides several relevant advan 
tages. The main advantage lies in that the prosthesis of the 
invention allows for a drastic reduction of the time required 
for the in situ anastomoses of the prosthesis itself and obviates 
the need for extracorporeal circulation and organ protection 
systems. Hence, it signi?cantly reduces surgical and anaes 
thesia times, leading to optimal treatment of the aneurysm 
pathology of the aortic arch and of the thoraco-abdominal 
aorta. 
Other advantages, features and operation modes of the 
present invention will be elucidated in the following detailed 
description of some of the embodiments thereof, given by 
way of example and not wholly exhaustive. Reference will be 
made to the annexed drawings, wherein: 
FIG. 1 shows a schematic front perspective view of an 
embodiment of the vascular endoprosthesis according to the 
present invention; 
FIG. 2 shows a cross section of the prosthesis of FIG. 1 
taken along line A-A of the latter Figure; 
FIG. 2A illustrates some geometric parameters of a com 
ponent of the prosthesis of FIG. 1; 
FIG. 3 shows another cross section of the prosthesis of FIG. 
1, taken along line B-B of the latter Figure; 
FIG. 4 shows a perspective view of the endoprosthesis of 
FIG. 1 implanted in correspondence of a section of the aortic 
arch; and 
FIG. 5 shows a partially sectional perspective view of the 
endoprosthesis of FIG. 1 during its insertion in correspon 
dence with the section of the related aortic arch, before the 
opening of the ends equipped with metal supports and with 
part of the prosthesis still external to the aneurysm. 
Initially referring to FIG. 1, a vascular endoprosthesis 
according to an embodiment of the invention is generally 
denoted by 1. In the present example, the endoprosthesis 1 is 
conceived to be implanted in correspondence with the aortic 
arch, and FIG. 4 shows the endoprosthesis 1 in situ. 
The endoprosthesis 1 comprises a substantially tubular 
main body 2 intended to be lodged in the internal lumen of the 
aortic arch, denoted by O in FIG. 4. 
Three secondary bodies branch off from main body 2. 
These are also tubular and marked 3, 4 and 5, respectively, 
each of which to be inserted into the internal lumen of a blood 
vessel originating from the aortic arch. In particular, the ?rst 
secondary body 3 is intended to be inserted into the right 
common carotid artery, denoted by R in FIG. 4, the second 
secondary body 4 into the left common carotid artery, denoted 
by L, and the third secondary body 5 into the left subclavian 
artery, denoted by S. 
Referring also to the section of FIG. 3, both the main body 
2 and the secondary bodies 3-5 are made of impermeable 
biocompatible material. Ideally, this material should be elas 
tically deformable and furrowed, (corrugated) e.g. Dacron. 
In correspondence with each of the two longitudinal end 
portions 21 and 22 of the main body 2 are respective engage 
ment means, denoted by 10 and 11, respectively, to secure end 
portions 21 and 22 to the internal wall of the corresponding 
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section of the aortic arch. Engagement means 10, 11 are 
shown in greater detail in FIG. 2. 
In this example, ?xing means 10 and 11 are based on 
self-expandable elastic elements set onto the internal walls of 
the blood vessels, in an expanded con?guration. Speci?cally, 
each of means 10, 11 consists of a shaped annular weft made 
of (biocompatible) elastically deformable material, exter 
nally surrounding and being supported by the respective end 
portions 21, 22 of the main body 2, the latter preferably made 
of the same biocompatible elastically deformable material. 
Preferably, in correspondence with said ends 21, 22, the mate 
rial should not be furrowed. (corrugated) 
In the present example said weft is formed by three inde 
pendent metallic annular elements, denoted by 101, 102 and 
103, respectively, for the means 10, each having a substan 
tially sinusoidal or loop-shaped pro?le. These annular ele 
ments are circumferentially arranged onto the main body 2 
and longitudinally spaced in correspondence with the respec 
tive end portion 21, 22. Preferably, and analogously to stent 
type securing systems already used in existing endoprosthe 
ses, the means 10, 11 are made of a shape retentive material, 
typically thermally preformed Nitinol or an alloy thereof. 
The annular elements of 101-103 type are secured on the 
end portions 21, 22 of the main body 2, e.g. by suture. 
As shown in FIG. 2A, preferably each annular element 
101-103 has a pitch P equal to about 10 mm, a loop widthA 
equal to about 8 mm and a wire diameter d comprised in a 
range of about 0.1-1.0 mm. 
Moreover, the engagement means 10, 11 each preferably 
involve a distal section T of the main body 2, of an approxi 
mate length comprised between 2-3 cm and of diameter, or 
gauge, D ranging between 26-46 mm. 
Each of the secondary bodies 3-5 further comprises, in 
correspondence with a respective distal end 31, 41, 51 
thereof, respective engagement means 13, 14, 15, having an 
overall con?guration analogous to that of the above-de 
scribed means 10, 11. 
Of course, the speci?c dimensions and extension of 
engagement means 13-15 of the secondary bodies 3-5 will be 
adapted to the con?guration of the respective blood vessel of 
insertion. In particular, for the secondary bodies 3-5 the pitch 
P could equal about 2 mm, a wire diameter d equal to about 
0.4 mm and a distal section, concerned by means 13-15, of 
length T equal to about 20 mm and diameter D equal to about 
8-14 mm. 
Preferably, in correspondence with engagement means 10, 
11 and 13-15 the diameter of the respective main 2 and 
secondary 3-5 bodies (and therefore that of the related annu 
lar elements) is oversized with respect to that of the respective 
blood vessel in a percentage equal to about 10-15% of the 
diameter of the vessel itself, and this in order to allow for 
improved securing in situ of the endoprosthesis 1. 
The provision of the engagement means only distally to 
each of the bodies 2-5 allows for improved adaptation to the 
anatomical site of the endoprosthesis 1 as a whole, leaving the 
central part of the main body 2 and of the secondary bodies 
3-5 free for adaptation. 
The engagement means 10, 11 and 13-15 assume an initial 
con?guration of minimal encumbrance, shown in FIG. 5, in 
which they are compressed or folded to allow for insertion of 
the respective body 2-5 into the related blood vessel, and a 
second unfolded or extended con?guration, shown in FIG. 4, 
in which they engage the wall of the blood vessel itself, 
securing the endoprosthesis 1 in situ. 
The engagement means 10, 11 and 13-15 can be remotely 
controlled (maneuvered) to allow transition from the ?rst to 












the endoprosthesis 1 comprises a fourth tubular body 6 form 
ing a maneuvering channel and arranged in a position sub 
stantially centered with respect to the main body 2 and, with 
the endoprosthesis in situ, below the secondary bodies 3-5. In 
the present example, maneuvering channel 6 has a diameter 
of about 10 mm. This maneuvering channel 6 can house one 
or more maneuvering elements 7 accessible from the outside, 
and in particular, as shown in the example in FIG. 5, several 
maneuvering wires to unfold each of the engagement means 
10,11 and 13-15. 
Upon implant of the endoprosthesis 1, the procedure 
described below is carried out, with reference to the example 
applicable to the aortic arch and the related epiaortic vessels. 
First, the aortic segment to be treated is exposed, using a 
conventional surgical approach of codi?ed cuts, such as 
median sternotomy or bilateral thoracotomy for the aortic 
arch or thoracophrenolaparotomy for the thoraco-abdominal 
aorta. 
The portions of blood vessels at which the engagement 
means 10, 11 and 13-15 are to be positioned are non-aneu 
rysmal sections adjacent to the aneurysmal portions. At each 
of the “healthy” portions, the physician, usually a vascular 
surgeon, performs a “purse string”, a technique familiar to 
experts in the ?eld and consisting in a pair of side-by-side 
stitches intended to constrict the section of vessel involved 
when pulled. 
The example presented is of ?ve “purse string” performed 
on healthy arterial wall, i.e. at the level of the ascending aorta 
(in correspondence with the end portion of the proximal end 
21 of the endoprosthesis 1), at the level of the descending 
thoracic aorta (in correspondence with the ?nal position of 
the distal end 22) and at the level of the epiaortic vessels (in 
correspondence with the ?nal position of the collateral ends 
31, 41 and 51 relating to the right common carotid artery R, 
the left common carotid artery L and the left subclavian artery 
S, respectively). 
After partial heparinization and using the well-known 
Seldinger technique, ?ve ends of the endoprosthesis 1 are 
inserted, containing the rapid-expansion engagement means 
10, 11 and 13-15, which are held in place by the ?ve previ 
ously performed purse strings and held in compressed con 
?guration by the maneuvering wires 7. 
Upon positioning the endoprosthesis liwhich is not yet 
operativeias mentioned above, the ?ve ends 21, 22, 31, 41 
and 51 are unfolded, i.e. brought from the compressed con 
?guration to the extended one, in the following sequence: 
I. left subclavian artery-related end 51, 
II. left carotid artery-related end 41, 
III. right carotid artery-related end 31, 
IV. proximal aorta-related end 21, 
V. distal aorta-related end 22. 
With the unfolding of the engagement means 10, 11 and 
13-15 anastomeses are executed with the aortic arch O and 
one of the above mentioned epiaortic vessels R, L and S. Note 
that the engagement means 10, 11 and 13-15 allows for the 
performance of the anastomoses not though a vascular suture, 
but rather through an endovascular-type release system; thus 
we may in effect de?ne it as “endoanastomosis”. 
The time of execution for the ?ve anastomoses is envisaged 
to be less than two minutes, certainly brief enough as not to 
create ischemic problems to the brain. 
Of course, each of the maneuvering wires 7 of the channel 
6 could be indicated by a suitable identifying element, e. g. an 
alphanumeric character, of the respective maneuvered 
engagement means 10, 11 and 13-15, visible from the outside. 
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The above-indicated sequence (l)-(V) allows for effective 
purging of air from the epiaortic trunks, preventing the risk of 
emboliZing the brain. 
It should be noted that the proposed con?guration, in which 
the ?ve ends of the maneuvering wires 7 issue from the sole 
collateral branch of the prosthesis 1 not equipped with stents, 
i.e. from the maneuvering channel 6, also facilitates control of 
the endoprosthesis 1 itself and the purging of air to the out 
side. 
Once the endoprosthesis 1 in place is operating, and after 
checking that the aneurysmal sac is no longer supplied as it is 
excluded from the circulation, the aneurysm is opened up. 
Note that in the present example, since the collateral 
branch 3 is inserted directly into the right common carotid 
artery R, and not into the brachiocephalic trunk (in order to 
simplify and unify the gauges of the collateral branches) a 
surgical revascularization of the right subclavian artery 
should be provided for; such a revascularization can be car 
ried out at leisure at the conclusion of the procedure by using 
the collateral branch 6. 
This particular endoprosthesis may also be used for 
replacement of the thoraco-abdominal aorta, in such case 
using four secondary bodies to be inserted into the celiac 
tripod, the superior mesenteric artery, the right renal artery 
and the left renal artery. 
Moreover, in case of need the prosthesis described hereto 
may also be used in conventional surgery, by resecting the 
proximal or distal end equipped with a stent (or by removing 
the endoanastomosis site) and suturing it to the residual (as 
cending and/or descending) aortic stump, for highly exten 
sive pathologies, such as acute type A dissections or Marfan 
syndrome. 
Furthermore, it will be appreciated that this invention 
means that a single item can ful?ll the needs for treatment of 
the aortic arch and of the thoraco-abdominal aorta, thus sim 
plifying its implementation and marketing. 
Thanks to its simplicity and speed of use, the invention also 
offers the potential of expanding the range of operators who 
can carry out vascular prosthetic ?tting surgery, increasing 
then number of potential bene?ciaries to include vascular 
surgery centers currently not able to provide these types of 
treatment. 
It should be apparent by now that the above-described 
vascular prosthesis would drastically reduce surgical times 
from the current approximate 120-180 min to the 4-5 min 
required for preparation of the entire technique. 
The invention further refers to a method of treating vascu 
lar pathologies that, in its broadest de?nition envisages: 
providing an endoprosthesis as de?ned above, and com 
prising in particular a substantially tubular main body 
capable of being introduced into the internal lumen of a 
main blood vessel and at least one secondary body, also 
basically tubular and originating from said main body, 
capable of being introduced into the internal lumen of a 
secondary blood vessel branching off the main vessel; 
inserting said endoprosthesis into the main and secondary 
blood vessels; and 
setting and securing the endoprosthesis in position. 
The present invention has hereto been described with ref 
erence to preferred embodiments thereof. It is understood that 
there might be other embodiments referable to the same 
inventive principle, all falling within the protective scope of 
the claims hereinafter. 
The invention claimed is: 
1. A vascular endopro sthesis capable of being set internally 












a substantially tubular main body, to be housed in the 
internal lumen of a main blood vessel; 
at least one secondary body, also substantially tubular, and 
originating from and ?xed to said main body, to be 
housed in the internal lumen of a blood vessel branching 
off the main vessel; 
engagement means, associated with and ?xed to each of 
said main body and secondary body and arranged in 
correspondence with at least one respective longitudinal 
end portion of each, apt to hold said end portions onto 
the internal wall of the respective blood vessel; and 
a maneuvering channel originating from said main body 
and, wherein the maneuvering channel is con?gured for 
remotely controlling the con?guration of said engage 
ment means; 
wherein said vascular endoprosthesis is pre-assembled prior 
to being implanted in situ. 
2. The endoprosthesis according to claim 1, wherein said 
engagement means are apt to assume a ?rst con?guration of 
minimal encumbrance, allowing for insertion of the respec 
tive main or secondary body into the related blood vessel, and 
a second unfolded con?guration, engaging the wall of the 
blood vessel, securing in position the respective longitudinal 
end of said main or secondary body. 
3. The endoprosthesis according to claim 2, wherein said 
engagement means are apt to be circumferentially com 
pressed to assume said con?guration of minimal encum 
brance. 
4. The endoprosthesis according to claim 1, wherein said 
engagement means are self-expandable. 
5. The endoprosthesis according to claim 1, wherein said 
engagement means are arranged onto the external wall of the 
respective main or secondary body. 
6. The endoprosthesis according to claim 1, wherein said 
engagement means comprise one or more elastically deform 
able elements. 
7. The endoprosthesis according to claim 6, wherein said or 
each of said elastically deformable element or elements com 
prises an annular element circumferentially arranged onto the 
respective main or secondary body. 
8. The endoprosthesis according to claim 6, wherein said or 
each of said elastically deformable elements comprises a 
loop-shaped element. 
9. The endoprosthesis according to claim 6, wherein said 
engagement means comprise several elastically deformable 
elements arranged longitudinally side-by-side along the 
respective main or secondary body. 
10. The endoprosthesis according to claim 1, wherein said 
engagement means comprise one or more stent-type ele 
ments. 
11. The endoprosthesis according to claim 1, wherein said 
engagement means comprise one or more shape memory 
type elements. 
12. The endoprosthesis claim 1, comprising maneuvering 
means that can be operated from the outside for remote con 
trol of the con?guration of said engagement means. 
13. The endoprosthesis according to claim 12, wherein said 
maneuvering means comprise one or more maneuvering 
wires. 
14. The endoprosthesis according to claim 12, wherein said 
maneuvering means bear identifying elements of the respec 
tive engagement means. 
15. The endoprosthesis according to claim 1, wherein said 
main body is apt to be housed in a portion of aorta. 
16. The endoprosthesis according to claim 15, wherein said 
main body is apt to be housed in the thoraco -abdominal aorta. 
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17. The endoprosthesis according to claim 15, wherein said 
main body is apt to be housed in the aortic arch. 
18. The endoprosthesis according to claim 17, comprising 
a secondary body apt to be housed in the right carotid artery. 
19. The endoprosthesis according to claim 17, comprising 
a secondary body apt to be housed in the left carotid artery. 
20. The endoprosthesis according to claim 17, comprising 
a secondary body apt to be housed in the left subclavian 
artery. 
21. The endoprosthesis according to claim 1, wherein said 
main body and/or said secondary body or bodies are made of 
an elastically deformable material. 
22. The endoprosthesis according to claim 1, wherein said 
main body and/or said secondary body or bodies are at least 
partially made of a furrowed (corrugated) material. 
23. The endoprosthesis according to claim 1, wherein, in 
correspondence of said engagement means, the diameter of 
the respective main and/or secondary body is oversized with 
respect to that of the respective blood vessel of insertion. 
24. The endoprosthesis according to claim 23, wherein said 
oversiZing is comprised in a range of about 10-15%. 
25. A method of treating vascular pathologies, comprising 
the following steps: 
(a) providing an endoprosthesis of claim 1, comprising a 
substantially tubular main body to be housed in the 
internal lumen of a main blood vessel and at least one 
secondary body, also substantially tubular and originat 
ing from said main body, apt to be housed in the internal 
lumen of a secondary blood vessel branching off the 
main vessel; 
(b) inserting said endoprosthesis into said main and sec 
ondary blood vessels; and 
(c) securing said endoprosthesis in position. 
26. The method according to claim 25, which is a method 
of treating aneurysmal blood vessels. 
27. The method according to claim 25, wherein said main 
blood vessel is the aorta. 
28. The method according to claim 27, wherein said step 
(b) provides for the insertion of the main body of the 
endoprosthesis into the aortic arch. 
29. The method according to claim 28, wherein said step 
(b) provides for the insertion of the secondary body or bodies 
of the endoprosthesis into one or more blood vessels selected 
from a group comprising the right carotid artery, left carotid 
artery and left subclavian artery. 
30. The method according to claim 29, wherein said step 
(c) provides for the clamping of the endoprosthesis in situ by 
activating related holding means according to the sequence: 
(1) left subclavian artery; (11) left carotid artery; (111) right 
carotid artery; (IV) proximal aorta; (V) distal aorta. 
31. The method according to claim 27, wherein said step 
(b) provides for the insertion of the main body of the 
endoprosthesis into the thoraco-abdominal aorta. 
32. The method according to claim 25, wherein said step 







the endoprosthesis by temporary restriction of the internal 
vascular lumen of healthy vascular portions. 
33. The method according to claim 32, wherein said tem 
porary restriction of the internal lumen of healthy vascular 
portions is obtained by performing “purse string” in corre 
spondence with said portions. 
34. The method according to claim 25, providing for 
removal of a vascular portion external to the endoprosthesis, 
performed in a surgical procedure temporally separate from 
that of insertion of the endoprosthesis itself. 
35. The method according to claim 25, wherein said step 
(a) provides for the use of an endoprosthesis capable of being 
set internally to a blood vessel, in particular a portion of aorta, 
comprising: 
a substantially tubular main body, to be housed in the 
internal lumen of a main blood vessel; 
at least one secondary body, also substantially tubular, and 
originating from and ?xed to said main body, to be 
housed in the internal lumen of a blood vessel branching 
off the main vessel; 
engagement means, associated with and ?xed to each of 
said main body and secondary body and arranged in 
correspondence with at least one respective longitudinal 
end portion of each, apt to hold said end portions onto 
the internal wall of the respective blood vessel; and 
a maneuvering channel originating from said main body 
and, wherein the maneuvering channel is con?gured for 
remotely controlling the con?guration of said engage 
ment means; 
wherein said vascular endoprosthesis is pre-assembled prior 
to being implanted in situ. 
36. A vascular endoprosthesis capable of being set inter 
nally to a blood vessel, in particular a portion of aorta, com 
prising: 
a substantially tubular main body, to be housed in the 
internal lumen of a main blood vessel; 
a plurality of secondary bodies, which are substantially 
tubular and ?xed to said main body, to be housed in the 
internal lumen of a blood vessel branching off the main 
vessel; 
engagement means, which is ?xed to each of said main 
body and secondary body, arranged in correspondence 
with at least one respective longitudinal end portion of 
each, apt to hold said end portions onto the internal wall 
of the respective blood vessel; and 
a maneuvering channel originating from said main body 
and, wherein the maneuvering channel is con?gured for 
remotely controlling the con?guration of said engage 
ment means; 
wherein said main body and said secondary bodies are made 
as a single body, and said vascular endoprosthesis is pre 
assembled prior to being implanted in situ. 
* * * * * 
